Setting Up a Medical Tourism Agency in Japan: Business Manager Visa and Hospital Partnership Compliance

This article is written by a Japanese local.

“Our enterprise plans to launch a medical tourism and cross-border healthcare coordination agency in Japan, targeting affluent international patients for precision cancer screenings (PET-CT), proton/heavy-ion beam radiation therapy, and regenerative medicine. How do foreign founders obtain the Business Manager visa?”

“Even if we satisfy the revised 30 million yen capital and full-time employee mandates, can we obtain visa approval if formal partnership agreements with major Japanese university hospitals and clinics are still in progress?”

Driven by Japan’s world-leading healthcare infrastructure and growing inbound demand for advanced medical checkups, foreign entrepreneurs are rapidly establishing cross-border healthcare coordination companies in Japan.

However, immigration review for medical tourism agencies is evaluated under one of the strictest anti-fraud scrutiny frameworks among all service sectors.

Immigration examiners intensely scrutinize whether the applicant is merely an illegitimate paper broker lacking verifiable medical partnerships, whether the business model violates Japan’s Medical Care Act regarding patient referral kickbacks, and whether the foreign managing director will unlawfully perform routine unspecialized physical labor (e.g., serving as an on-site hospital interpreter or airport shuttle driver).

This guide explains how to construct binding Medical Institution Partnership Agreements (MOUs), satisfy the 30 million yen capital and regular employment rules, and navigate the METI/MOFA Registered Medical Guarantor licensing framework.

1. Establishing Operational Authenticity: Eliminating the “Paper Broker” Trap

Immigration officers closely inspect the commercial pipeline connecting overseas patients with domestic Japanese medical facilities. Operating a simple marketing website is entirely insufficient to prove operational reality:

Evaluation Metric	Non-Compliant Flaws (Causes of Refusal)	Proper Legal Standards for Approval
1. Hospital Affiliations	Vague projections stating “partnerships will be negotiated after visa issuance” (Zero executed agreements)	Submit executed Memorandums of Understanding (MOUs) or binding partnership contracts with licensed Japanese medical institutions.
2. Revenue Stream Legitimacy	Relying on referral commissions/kickbacks paid by hospitals (Suspected violation of Medical Care Act restrictions)	Revenue structured transparently as coordination fees paid by patients for medical translation, concierge services, and logistics support.
3. Patient Acquisition Pipeline	Abstract assertions regarding generic online marketing or social media advertising	Executed patient referral agreements with overseas travel agencies, VIP wealth managers, or private concierge clubs.

2. Essential Clauses in Hospital Partnership Agreements (MOUs)

To overcome immigration skepticism, sponsoring enterprises must secure formal agreements with at least one or two Japanese clinics or screening centers before filing, incorporating the following contractual clauses:

1. Specified Clinical and Diagnostic Scope:
   Clearly designate eligible treatment menus (e.g., Early Cancer Detection PET-CT, Comprehensive Executive Health Checkups, Autologous Stem Cell Therapies, Aesthetic Dermatology).
2. Operational Division of Responsibilities:
   Explicitly state that the coordination company handles intake record translation, appointment scheduling, qualified medical interpreters, and transportation, while the medical institution holds exclusive responsibility for medical diagnostics and clinical care.
3. Financial Settlement & Escrow Terms:
   Establish advance payment terms and non-recourse deposit mechanisms ensuring zero risk of medical expense default in Japan.

3. Capital Proof (30M JPY) and Precluding Routine Interpreting Duties

Under revised immigration standards, the enterprise must substantiate **30 million yen in deployed capital and at least one regular full-time staff member**:

① Strict Decoupling of Executive Duties from Routine Medical Interpreting

Under Article 73-2 of the Immigration Control Act, if a Business Manager visa holder personally acts as an on-site hospital interpreter in clinical consultation rooms or drives transport vans, it constitutes unauthorized unspecialized labor.

• Mandatory Full-Time Operations Staff: Employ at least one regular full-time employee (Japanese national, Permanent Resident, or qualifying resident) dedicated to hospital liaison, scheduling, and case management.
• Dedicated Medical Interpreters or Outsourced Master Contracts: Employ qualified medical interpreters (holding Engineer/Specialist in Humanities visas) or execute service agreements with established medical translation and luxury transportation agencies, demonstrating that the managing director focuses strictly on corporate management and institutional client acquisition.

4. Navigating the “Registered Medical Guarantor” Licensing Timing Deadlock

Foreign patients undergoing extensive medical treatment frequently enter Japan on a “Medical Stay Visa,” which requires a sponsorship guarantee issued by an accredited Registered Guarantor (Medical Coordinator) licensed by METI and the Ministry of Foreign Affairs (MOFA).

① The Startup Eligibility Dilemma

New corporate entities cannot immediately obtain Registered Guarantor status because licensing criteria demand operational track records and strict financial stability. Immigration examiners inevitably question how an unaccredited startup intends to bring foreign medical patients to Japan.

② Two-Phase Implementation Strategy in the Business Plan

• Phase 1: Outpatient Screenings Under Temporary Visitor Status
  Demonstrate that outpatient health checkups (PET-CT) and non-invasive aesthetic treatments do not require inpatient hospitalization and are legally conducted under standard Temporary Visitor (Tourist) status.
• Strategic Alliances with Existing Registered Guarantors:
  For severe cases requiring long-term treatment under the Medical Stay Visa, submit bilateral alliance agreements with established registered travel agencies or accredited medical coordinators to co-sponsor guarantor documentation.
• Phase 2: Post-Landing Accreditation Roadmap
  Detail a multi-year roadmap showing that after building compliant patient volume during initial fiscal years, the company will formally apply for direct METI Registered Guarantor status.

5. Mandatory Evidentiary Package for Medical Tourism Visa Filings

Corporate applicants must assemble an airtight evidentiary package verifying hospital commitments and operational privacy:

1. Executed Hospital Partnership Agreements (MOUs):
   Official bilateral agreements, institutional brochures, and confirmed clinical service menus from Japanese medical corporations.
2. Itemized Healthcare Packages and Fee Schedules:
   Marketing brochures and sample price schedules (e.g., Executive Oncology Screening Package, Stem Cell Anti-Aging Protocol) verifying fee transparency.
3. Dedicated Privacy-Compliant Physical Workspace:
   Commercial lease agreement and photographs showing a lockable, private office equipped with secure storage cabinets for confidential patient medical records, dedicated landlines, and corporate signage.
4. Verified 30 Million Yen Capital Inflow:
   Official banking documentation and overseas Telegraphic Transfer (TTM) records proving legitimate capital provenance.

6. Summary: Transforming Hospital Partnerships into Immigration Approvals

Launching a medical tourism business in Japan requires navigating complex cross-border healthcare compliance alongside strict statutory immigration standards.

Assuming that capital injection alone will secure visa approval without formal hospital partnerships will lead to immediate rejection under suspicion of unauthorized brokering.

By establishing verifiable hospital partnership contracts, separating executive governance from routine interpreting labor, and structuring phased guarantor alliances, foreign entrepreneurs can successfully secure their business footing in Japan’s premier healthcare sector.